Mark D. Chen

US·SEC (Form 4)

Skystar Bio-Pharmaceutical Co

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 08 May 2012 for SKYSTAR BIO-PHARMACEUTICAL CO, €41k.

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Mark D. Chen: trading record in brief

Mark D. Chen discloses dealings in Skystar Bio-Pharmaceutical Co to SEC (Form 4). Over a trading history stretching from 26 May 2009 to 4 May 2012, the count stands at 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 8 May 2012: a share grant of €41k, in Skystar Bio-Pharmaceutical Co. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.